Provided by Tiger Trade Technology Pte. Ltd.

Mesabi

22.73
+0.25001.11%
Post-market: 22.830.1000+0.44%19:51 EDT
Volume:27.23K
Turnover:615.41K
Market Cap:298.22M
PE:26.33
High:22.89
Open:22.36
Low:22.33
Close:22.48
52wk High:42.38
52wk Low:21.60
Shares:13.12M
Float Shares:13.11M
Volume Ratio:1.23
T/O Rate:0.21%
Dividend:0.89
Dividend Rate:3.92%
EPS(TTM):0.8632
EPS(LYR):1.06
ROE:59.68%
ROA:28.92%
PB:16.26
PE(LYR):21.50

Loading ...

Mesabi Trust Q2 FY26 Swings to Net Loss of USD 95,013; Revenue Drops 55.75% to USD 2.48 Million

Reuters
·
Yesterday

Mesoblast Financial Results and Corporate Update Webcast

GlobeNewswire
·
Aug 24

Metals Royalty Raises $165 Million to Fund Additional Mesabi Royalty

MT Newswires Live
·
Aug 21

Mesoblast completes patient treatment in MSB-DR004 in Phase 3 trial

TIPRANKS
·
Aug 17

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

GlobeNewswire
·
Aug 17

Mesabi Trust Receives $1.81 Million in Q2 Royalty Payments from Cleveland-Cliffs

Reuters
·
Aug 01

Mesabi Trust Declares $0.05 Per Unit Distribution Payable Aug. 20

Reuters
·
Jul 15

Press Release: Mesabi Trust Press Release

Dow Jones
·
Jul 15

The Metals Royalty Company Announces Completion of First Production Blast at Mesabi Metallics

TIPRANKS
·
Jul 14

Inter Launches Wearables in the U.S., Taking Banking Beyond the Phone

GlobeNewswire
·
Jul 13

Metals Company completes first production blast at Mesabi Metallics

TIPRANKS
·
Jul 13

Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?

Simply Wall St.
·
Jul 12

Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026

Dow Jones
·
Jul 10

Why Mesoblast (ASX:MSB) Is Up 9.3% After FDA Accepts Modular BLA Review For Rexlemestrocel-L

Simply Wall St.
·
Jul 04

Treasure Global Recieves Canadian MSB Registration for OXI Wallet Expansion

MT Newswires Live
·
Jul 02

Is Mesoblast (ASX:MSB) Undervalued Following FDA Progress For Rexlemestrocel L?

Simply Wall St.
·
Jul 02

Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs

GlobeNewswire
·
Jul 01

OwlTing Group (NASDAQ: OWLS) and Saber Money Open Settlement into India's US$860 Billion Export Economy

GlobeNewswire
·
Jun 29

Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility

Dow Jones
·
Jun 25

Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed?

Simply Wall St.
·
Jun 21